Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate. [electronic resource]
Producer: 20091015Description: 220-3 p. digitalISSN:- 1607-8454
- Adaptor Proteins, Signal Transducing
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- therapeutic use
- Benzamides
- DNA-Binding Proteins -- biosynthesis
- Female
- Humans
- Imatinib Mesylate
- LIM Domain Proteins
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy
- Male
- Metalloproteins -- biosynthesis
- Middle Aged
- Piperazines -- therapeutic use
- Prognosis
- Protein Kinase Inhibitors -- therapeutic use
- Protein-Tyrosine Kinases -- antagonists & inhibitors
- Proto-Oncogene Proteins -- biosynthesis
- Pyrimidines -- therapeutic use
- Survival Rate
- Young Adult
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.